PERTURB-Flow In vivo PERTURB-Flow: high-throughput single-cell perturbation screening for macrophage target discovery
- Coordinator
- Vrije Universiteit Brussel, Belgium
- Runs
- 1 April 2026 to 30 September 2027
- Status
- Running
- EU funding
- €150k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101291741
What the project is doing
In the project's own words, from its summary on CORDIS.
This project aims to deliver proof-of-concept for in vivo PERTURB-Flow, a breakthrough technology for the systematic discovery of therapeutic targets in macrophages. The proof-of-concept will focus on microglia, the brain’s resident macrophages, both in homeostatic and disease conditions. In parallel, we will engage industrial partners and perform business development, patent and freedom-to-operate analyses, laying the groundwork for valorization and spin-off development.
Together, these activities will establish a powerful platform that may move the macrophage field beyond its current scarcity of targets, providing a scalable pipeline for in vivo–validated therapeutic discovery.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Vrije Universiteit Brussel | Bruxelles / Brussel | Belgium | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI